Home » Topics » Regulatory » Patents

Patents
RSS

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996

Merck & Co. reports NK1 antagonists

Aug. 30, 1996

Novel antitumor compounds claimed by Kyorin/Sagami

Aug. 23, 1996

Erythromycin A 9-O-oxime derivatives from Zambon

Aug. 23, 1996

Terumo claims antithrombotic/antiallergy agents

Aug. 23, 1996

Fibrinogen antagonists in SmithKline Beecham's pipeline

Aug. 23, 1996

Corvas describes Factor Xa inhibitors

Aug. 23, 1996

More thrombin inhibitors from BioChem Pharma

Aug. 23, 1996

BioChem Pharma claims thrombin inhibitors for coagulopathies

Aug. 23, 1996

Santen reveals neutral endopeptidase inhibitors

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...